{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:13:12Z","timestamp":1780438392661,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T00:00:00Z","timestamp":1442188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s40261-015-0331-5","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T07:54:59Z","timestamp":1442217299000},"page":"675-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight\/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial"],"prefix":"10.1007","volume":"35","author":[{"name":"On behalf of the KIND-LM study investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Saisho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Manesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Meguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Jinzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,14]]},"reference":[{"issue":"16","key":"331_CR1","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation."},{"issue":"9733","key":"331_CR2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215\u201322.","journal-title":"Lancet."},{"issue":"9","key":"331_CR3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"SR Seshasai","year":"2011","unstructured":"Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829\u201341.","journal-title":"N Engl J Med."},{"issue":"3","key":"331_CR4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1304501","volume":"370","author":"DK Tobias","year":"2014","unstructured":"Tobias DK, Pan A, Jackson CL, O\u2019Reilly EJ, Ding EL, Willett WC, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370(3):233\u201344.","journal-title":"N Engl J Med."},{"issue":"3","key":"331_CR5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/dc14-1175","volume":"38","author":"PJHL Peeters","year":"2015","unstructured":"Peeters PJHL, Bazelier MT, Leufkens HGM, de Vries F, De Bruin ML. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity. Diabetes Care. 2015;38(3):495\u2013502.","journal-title":"Diabetes Care."},{"issue":"1","key":"331_CR6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140\u20139.","journal-title":"Diabetes Care."},{"issue":"10","key":"331_CR7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/dom.12293","volume":"16","author":"YG Kim","year":"2014","unstructured":"Kim YG, Hahn S, Oh TJ, Park KS, Cho YM. Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis. Diabetes Obes Metab. 2014;16(10):900\u20139.","journal-title":"Diabetes Obes Metab."},{"issue":"5","key":"331_CR8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.EJ14-0602","volume":"62","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, Saisho Y, Kawai T, Tanaka M, Meguro S, Irie J, et al. Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight\/obese patients with type 2 diabetes. Endocr J. 2015;62(5):399\u2013409.","journal-title":"Endocr J."},{"issue":"8","key":"331_CR9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40261-013-0098-5","volume":"33","author":"N Kodani","year":"2013","unstructured":"Kodani N, Saisho Y, Tanaka K, Kawai T, Itoh H. Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus. Clin Drug Invest. 2013;33(8):563\u201370.","journal-title":"Clin Drug Invest."},{"key":"331_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13340-012-0069-8","volume":"3","author":"Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society.","year":"2012","unstructured":"Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int. 2012;3:8\u201310.","journal-title":"Diabetol Int"},{"issue":"3","key":"331_CR11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s13340-011-0035-x","volume":"2","author":"Y Saisho","year":"2011","unstructured":"Saisho Y, Tanaka K, Abe T, Shimada A, Kawai T, Itoh H. Glycated albumin to glycated hemoglobin ratio reflects postprandial glucose excursion and relates to beta cell function in both type 1 and type 2 diabetes. Diabetol Int. 2011;2(3):146\u201353.","journal-title":"Diabetol Int."},{"issue":"6","key":"331_CR12","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"331_CR13","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00421.2006","volume":"293","author":"C Cobelli","year":"2007","unstructured":"Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, Caumo A, et al. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab. 2007;293(1):E1\u201315.","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"4","key":"331_CR14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/db13-1198","volume":"63","author":"C Cobelli","year":"2014","unstructured":"Cobelli C, Dalla Man C, Toffolo G, Basu R, Vella A, Rizza R. The oral minimal model method. Diabetes. 2014;63(4):1203\u201313.","journal-title":"Diabetes."},{"issue":"8","key":"331_CR15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ca.20543","volume":"20","author":"Y Saisho","year":"2007","unstructured":"Saisho Y, Butler AE, Meier JJ, Monchamp T, Allen-Auerbach M, Rizza RA, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20(8):933\u201342.","journal-title":"Clin Anat."},{"issue":"6","key":"331_CR16","first-page":"626","volume":"15","author":"K Kou","year":"2014","unstructured":"Kou K, Saisho Y, Jinzaki M, Itoh H. Relationship between body mass index and pancreas volume in Japanese adults. JOP. 2014;15(6):626\u20137.","journal-title":"JOP."},{"issue":"7","key":"331_CR17","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/diabetes.52.7.1786","volume":"52","author":"AM Chang","year":"2003","unstructured":"Chang AM, Jakobsen G, Sturis J, Smith MJ, Bloem CJ, An B, et al. The GLP-1 derivative NN2211 restores \u03b2-cell sensitivity to glucose in type 2 diabetic patients after a single dose. Diabetes. 2003;52(7):1786\u201391.","journal-title":"Diabetes."},{"issue":"6","key":"331_CR18","doi-asserted-by":"crossref","first-page":"E1115","DOI":"10.1152\/ajpendo.00705.2009","volume":"298","author":"C Dalla Man","year":"2010","unstructured":"Dalla Man C, Micheletto F, Sathananthan A, Rizza RA, Vella A, Cobelli C. A model of GLP-1 action on insulin secretion in nondiabetic subjects. Am J Physiol Endocrinol Metab. 2010;298(6):E1115\u201321.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 3","key":"331_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1463-1326.2009.01075.x","volume":"11","author":"L Blonde","year":"2009","unstructured":"Blonde L, Russell-Jones D. The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies. Diabetes Obes Metab. 2009;11(Suppl 3):26\u201334.","journal-title":"Diabetes Obes Metab."},{"issue":"2","key":"331_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.diabres.2008.03.018","volume":"81","author":"Y Seino","year":"2008","unstructured":"Seino Y, Rasmussen MF, Zdravkovic M, Kaku K. Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: a double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract. 2008;81(2):161\u20138.","journal-title":"Diabetes Res Clin Pract."},{"issue":"8","key":"331_CR21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/dmrr.2443","volume":"29","author":"Y Bi","year":"2013","unstructured":"Bi Y, Tong GY, Yang HJ, Cai MY, Ma JH, Liang J, et al. The beneficial effect of metformin on beta-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes. Diabetes Metab Res Rev. 2013;29(8):664\u201372.","journal-title":"Diabetes Metab Res Rev."},{"issue":"6","key":"331_CR22","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc12-1235","volume":"36","author":"K Kodama","year":"2013","unstructured":"Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, Butte AJ. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care. 2013;36(6):1789\u201396.","journal-title":"Diabetes Care."},{"key":"331_CR23","first-page":"1","volume":"20","author":"HM Lando","year":"2012","unstructured":"Lando HM, Alattar M, Dua AP. Elevated amylase and lipase in patients using GLP-1 receptor agonists or DPP-4 inhibitors in the outpatient setting. Endocr Pract. 2012;20:1\u201316.","journal-title":"Endocr Pract."},{"issue":"7","key":"331_CR24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/dom.12262","volume":"16","author":"C Mathieu","year":"2014","unstructured":"Mathieu C, Rodbard HW, Cariou B, Handelsman Y, Philis-Tsimikas A, Ocampo Francisco AM, et al. A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON). Diabetes Obes Metab. 2014;16(7):636\u201344.","journal-title":"Diabetes Obes Metab."},{"issue":"11","key":"331_CR25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ijo.2013.120","volume":"37","author":"TA Wadden","year":"2013","unstructured":"Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM, et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study. Int J Obes. 2013;37(11):1443\u201351.","journal-title":"Int J Obes."},{"issue":"9","key":"331_CR26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJMp1001578","volume":"362","author":"M Parks","year":"2010","unstructured":"Parks M, Rosebraugh C. Weighing risks and benefits of liraglutide\u2013the FDA\u2019s review of a new antidiabetic therapy. N Engl J Med. 2010;362(9):774\u20137.","journal-title":"N Engl J Med."},{"issue":"7","key":"331_CR27","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s00125-014-3231-y","volume":"57","author":"JJ Meier","year":"2014","unstructured":"Meier JJ, Nauck MA. Risk of pancreatitis in patients treated with incretin-based therapies. Diabetologia. 2014;57(7):1320\u20134.","journal-title":"Diabetologia."},{"key":"331_CR28","doi-asserted-by":"crossref","first-page":"g2780","DOI":"10.1136\/bmj.g2780","volume":"348","author":"JL Faillie","year":"2014","unstructured":"Faillie JL, Azoulay L, Patenaude V, Hillaire-Buys D, Suissa S. Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study. BMJ. 2014;348:g2780.","journal-title":"BMJ."},{"key":"331_CR29","doi-asserted-by":"crossref","first-page":"g2366","DOI":"10.1136\/bmj.g2366","volume":"348","author":"L Li","year":"2014","unstructured":"Li L, Shen J, Bala MM, Busse JW, Ebrahim S, Vandvik PO, et al. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies. BMJ. 2014;348:g2366.","journal-title":"BMJ."},{"issue":"9","key":"331_CR30","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMp1314078","volume":"370","author":"AG Egan","year":"2014","unstructured":"Egan AG, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, et al. Pancreatic safety of incretin-based drugs\u2014FDA and EMA assessment. N Engl J Med. 2014;370(9):794\u20137.","journal-title":"N Engl J Med."},{"issue":"1","key":"331_CR31","doi-asserted-by":"crossref","first-page":"G10","DOI":"10.1152\/ajpgi.00077.2010","volume":"299","author":"SG Barreto","year":"2010","unstructured":"Barreto SG, Carati CJ, Toouli J, Saccone GT. The islet-acinar axis of the pancreas: more than just insulin. Am J Physiology Gastrointest Liver Physiol. 2010;299(1):G10\u201322.","journal-title":"Am J Physiology Gastrointest Liver Physiol."},{"issue":"3","key":"331_CR32","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/db14-0883","volume":"64","author":"JA Koehler","year":"2015","unstructured":"Koehler JA, Baggio LL, Cao X, Abdulla T, Campbell JE, Secher T, et al. Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis. Diabetes. 2015;64(3):1046\u201356.","journal-title":"Diabetes."},{"issue":"7","key":"331_CR33","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db12-1686","volume":"62","author":"AE Butler","year":"2013","unstructured":"Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes. 2013;62(7):2595\u2013604.","journal-title":"Diabetes."},{"issue":"7","key":"331_CR34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/dom.12257","volume":"16","author":"S Bonner-Weir","year":"2014","unstructured":"Bonner-Weir S, In\u2019t Veld PA, Weir GC. Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies. Diabetes Obes Metab. 2014;16(7):661\u20136.","journal-title":"Diabetes Obes Metab."},{"issue":"7","key":"331_CR35","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2337\/db13-0520","volume":"62","author":"SE Kahn","year":"2013","unstructured":"Kahn SE. Incretin therapy and islet pathology: a time for caution. Diabetes. 2013;62(7):2178\u201380.","journal-title":"Diabetes."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0331-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-015-0331-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0331-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:28:55Z","timestamp":1559489335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-015-0331-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1007\/s40261-015-0331-5","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]}}}